Values ​​to follow in Paris and in Europe – 01/07/2024 at 09:03

Values ​​to follow in Paris and in Europe – 01/07/2024 at 09:03
Values ​​to follow in Paris and in Europe – 01/07/2024 at 09:03

* AIR FRANCE AIRF.PA and Transavia France said on Monday that they were seeing pressure on unit revenues expected for the summer season, attributable to the Paris 2024 Olympic Games and having a negative impact of 160 to 180 million euros.

* THALES TCFP.PA – Searches took place from Wednesday to Friday at the headquarters of various group companies in France, the Netherlands and Spain, as part of two preliminary investigations into alleged acts of corruption and trafficking influence of a foreign public official, we learned on Saturday from a judicial source.

* RENAULT RENA.PA – Saudi Aramco will acquire a 10% stake in Horse Powertrain, the joint venture between Renault and Geely in thermal engines, the Chinese group announced on Friday.

* AIRBUS AIR.PA has announced an agreement to take over some of the troubled Spirit AeroSystems business as part of Boeing’s acquisition of Spirit. The European planemaker said it would pay a symbolic $1 for Spirit’s assets, which will compensate Airbus for $559 million.

* ATOS ATOS.PA announced on Sunday that it had reached an agreement on the terms of its financial restructuring with a group of banks and its bondholders, which will place the IT services specialist in the hands of its creditors.

* VALNEVA VLS.PA announced on Monday that it had received marketing authorization in Europe for its vaccine against chikungunya.

* CASINO CASP.PA has signed a firm agreement with Tikehau Capital for the sale, in the second half of 2024, of a portfolio of 30 real estate assets totaling more than 200 million euros.

* DASSAULT SYSTEMES DAST.PA announced on Monday that it was partnering with Mistral AI to offer industrial solutions.

* APERAM APAM.AS announced on Monday that it is confirming its forecasts for the second quarter of 2024.

* ASTRAZENECA AZN.L said on Monday that the European drug regulator had accepted a marketing authorisation application for its experimental COVID-19 prevention drug sipavibart for accelerated assessment.

* NESTLE NESN.S is targeting stable sales volume growth from the second quarter and for the rest of the year, its chief executive told the Swiss newspaper “Schweiz am Wochenende”.

(Written by Claude Chendjou)

-

-

PREV How Artificial Intelligence and Machine Learning Are Transforming E-Commerce
NEXT $600 million investment announced in fiber optics